Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6591551 | 0.84 | MAOA (0.34) | MAOAMAOBBACE1 | |
| SCHEMBL4602883 | 0.83 | BACE1 (0.44) | MAOAMAOBBACE1 | |
| SCHEMBL30127826 | 0.78 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL5153339 | 0.76 | MAOA (0.61) | MAOAMAOB | |
| SCHEMBL30127898 | 0.75 | GABRA1 (0.35) | MAOAMAOB | |
| SCHEMBL943476 | 0.72 | APOBEC3G (0.33) | — | |
| SCHEMBL3598536 | 0.71 | MAOA (0.36) | MAOAMAOB | |
| SCHEMBL31358088 | 0.71 | MAOA (0.36) | MAOAMAOB | |
| SCHEMBL3267392 | 0.70 | RAB9A (0.40) | MAOAMAOBBACE1 | |
| SCHEMBL10509506 | 0.69 | MTNR1A (0.46) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4101852-A1 | PYRIDOPYRIMIDINONE COMPOUND AND APPLICATION THEREOF | Bebetter Med Inc. (CN) | 2022-12-14 | — | — | EP | disclosed |
| US-20220389013-A1 | PYRIDOPYRIMIDINONE COMPOUNDS AND APPLICATIONS THEREOF | BEBETTER MED INC. (CN) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389013-A1 | PYRIDOPYRIMIDINONE COMPOUNDS AND APPLICATIONS THEREOF | KRAS, NRAS, HRAS | MAOA 4328/4885MAOB 3233/4885BACE1 3374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.